🇰🇷 Amondys 45 in South Korea

Amondys 45 (CASIMERSEN) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Amondys 45 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in South Korea

Frequently asked questions

Is Amondys 45 approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Amondys 45 in South Korea?

Sarepta is the originator. The local marketing authorisation holder may differ — check the official source linked above.